Podcast episode 10 (in German)
Methylene blue – wonder drug or hype?
July 4, 2026
A dye from the 19th century, one of the very first synthetic medicines and today a darling of the nootropics scene: methylene blue has a history like hardly any other molecule. The episode shows what is plausible about it and where it gets tricky.
What it is about
Methylene blue was invented as a dye around 150 years ago, then killed malaria pathogens and was a tool of Paul Ehrlich, the pioneer of the “magic bullet”. To this day it is approved as an injection for an emergency in which the blood temporarily no longer transports oxygen. The biohacking scene is interested in something else: in the mitochondria it can channel electrons past bottlenecks in the energy chain, especially in stressed or aged cells. The episode explains why the amount is decisive, which interactions one needs to know and why quality matters. At the end stands a fascinating molecule with plausible effects and thin evidence for biohacking.
Key points
- Methylene blue was invented as a dye in the 19th century and became one of the first synthetic medicines; as of July 2026, it is approved as an injection for a special poisoning of the blood.
- In a small study, a metabolic brain scan after low-dose methylene blue showed more activity and better blood flow; this is the origin of its reputation as a focus agent.
- Methylene blue follows the principle of hormesis: in small amounts it acts as an antioxidant, in large amounts it becomes a cell stressor itself, that is, pro-oxidant.
- Methylene blue inhibits the enzyme MAO, which breaks down serotonin; together with antidepressants the effect can build up to serotonin syndrome.
- In a hereditary G6PD deficiency of the red blood cells, methylene blue can cause the blood cells to break down, and many people do not know about this defect without a test.
- A methylene blue derivative was tested against Alzheimer’s in large trials and missed the primary goals: a beautiful mechanism that did not hold up in rigorous human trials.
- Industrial-grade product can be contaminated with heavy metals; pharmaceutical quality is often labeled “USP grade”; in addition, methylene blue can distort oxygen measurement on the finger.
Where the data stop
For biohacking the evidence is thin: the brain data come from one small study, the mechanism is elegant, but the big Alzheimer’s hopes have burst. Many users report more focus, clarity and less brain fog; that may be real, but it does not replace a clean study. Against dementia, long COVID and the many other complaints for which it is advertised online, methylene blue is not a proven remedy.
Three things decide between benefit and harm: amount, purity and interactions. Anyone taking antidepressants or other psychotropic drugs, or who might have a G6PD deficiency, stays away from it. Before surgery and examinations it belongs in a conversation with the doctor or anesthetist. Blue urine and a blue tongue, by contrast, are harmless.
Listen (in German)
Listen on Spotify Listen on Apple Podcasts Listen on Amazon Music
Published on July 4, 2026.
The topic in the database
- A dye from the 19th century and an approved emergency drug: at low concentration, methylene blue transfers electrons in the mitochondriaMethylene Blue
All episodes in the app (German)
Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-10-09.